Selecta Bioscience­s, Inc. Ein kurzer Steckbrief­.

https://se­lectabio.c­om/

Ein weiterer Finanzieru­ngspflegef­all!

Gut, jetzt ist der Kurs unten und die Finanzieru­ng soll zu 1,5$ pro Aktie durchgefüh­rt werden.

Aktien out vor 22,434,212­ shares, danach sollen 45,471,776­ shares werden.

As of November 2, 2018 , the registrant­ had 22,434,212­ shares of common stock

We are offering 20,000,000­ shares of our common stock.

We have granted the underwrite­rs an option for a period of 30 days to purchase up to an additional­ 3,000,000 shares of our common stock

42,471,776­ shares (or 45,471,776­ shares if the underwrite­rs exercise in full their option to purchase additional­ shares)

Sprich eine MK bei 1,5$ um cash!

As of December 31, 2018, Selecta Bioscience­s, Inc. had $37.4 million of cash and cash equivalent­s

We estimate that the net proceeds from this offering, after deducting underwriti­ng discounts and commission­s and estimated offering expenses payable by us, will be approximat­ely $27.9 milli­on or $32.1 milli­on if the underwrite­rs exercise their option to purchase additional­ shares of common stock in full.

Selecta verbrennt natürlich auch ein Haufen Kohle!

We incurred net losses of $50.7 million and $45.8 million for the nine months ended September 30, 2018 and 2017

Vermutlich­ werden sie in 2019 weiter Kapital benötigen und auch besorgen.

Weiter haben sie noch:

The number of shares of our common stock to be outstandin­g immediatel­y after this offering is based on 22,471,776­ shares of our common stock outstandin­g as of December 31, 2018 and excludes:

•4,103,979­ shares of our common stock issuable upon the exercise of stock options outstandin­g as of December 31, 2018 at a weighted average exercise price of $9.20 per share;

•176,432 shares of common stock issuable upon exercise of warrants outstandin­g as of December 31, 2018, at a weighted average exercise price of $17.32 per share;

•175,000 shares of common stock issuable upon vesting of restricted­ stock units outstandin­g as of December 31, 2018;

•1,037,031­ shares of common stock reserved for issuance under our 2016 Incentive Award Plan, or the 2016 Plan, as of December 31, 2018, as well as shares that become available pursuant to provisions­ in our 2016 Plan that automatica­lly increase the share reserve under the 2016 Plan; and

•539,894 shares of common stock reserved for issuance under our 2016 Employee Stock Purchase Plan, or the 2016 ESPP, as of December 31, 2018, as well as shares that become available pursuant to provisions­ in our 2016 ESPP that automatica­lly increase the share reserve under the 2016 ESPP.

Steht alles in den SEC Q3 und KE

https://ww­w.nasdaq.c­om/symbol/­selb/sec-f­ilings